Results 81 to 90 of about 49,331 (120)

Intravenous Immunoglobulin Induces Sustained Hemostatic Responses in IgM Paraprotein-Associated Acquired Von Willebrand Syndrome. [PDF]

Cureus
Alishah M, Imdad S, Jaffri M, Eisner R.
europepmc   +1 more source

A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges - A case report. [PDF]

Res Pract Thromb Haemost
Derikx F, Merry I, Willemsen D, Beckers E, Henskens Y, Heubel-Moenen F.   +5 more
europepmc   +1 more source

Therapeutic Plasma Exchange in Immune-Mediated Thrombotic Thrombocytopenic Purpura: From Cornerstone to Contextualized Therapy. [PDF]

J Clin Med
Özcan F, Brinkhoff A, Wendt R.
europepmc   +1 more source

Endothelial Biomarkers Predict Clinical Deterioration in Acute Pancreatitis. [PDF]

J Clin Pract Res
Agayev R, Mammadov A, Iskandarov E, Idrisov F.   +3 more
europepmc   +1 more source

Preoperative identification and multidisciplinary management of von Willebrand disease in atrial septal defect closure: a case report. [PDF]

Front Cardiovasc Med
Peng W, Wei Q, Yang J, Liu X.
europepmc   +1 more source

Pediatric Essential Thrombocythemia With a Novel <i>CALR</i> Mutation: A Case Report. [PDF]

EJHaem
Tsuji K, Uemura S, Fujikawa T, Yamamoto N, Kozaki A, Saito A, Ishida T, Mori T, Yoshida M, Okutani T, Hasegawa D.   +10 more
europepmc   +1 more source

Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities. [PDF]

Blood Vessel Thromb Hemost
Story CM, Yanek L, Vaidya D, Brown J, Francischetti IMB, Nyquist P, Chaturvedi S.   +6 more
europepmc   +1 more source

Mouse models to study von Willebrand factor in inflammation: a scoping review. [PDF]

Intensive Care Med Exp
Masood H, DeYoung V, Andrisani P, Kodeeswaran A, Sparring T, Arora J, Savic N, Babulic JL, Matino D, Liaw PC, Kretz CA, Fox-Robichaud A.   +11 more
europepmc   +1 more source

Selected biomarkers of coagulation, inflammation, and vascular tone in young women with normal weight obesity. [PDF]

Int J Obes (Lond)
Pluta W, Lubkowska A, Dudzińska W.
europepmc   +1 more source

Von Willebrand factor A1 blockade prevents platelet-mediated sustained occlusion for the treatment of arterial thrombosis. [PDF]

Commun Biol
Mihalko EP, Kar R, Holthaus B, Rassam RMG, Sharma R, Wheeler D, Nimjee SM, Shea SM.   +7 more
europepmc   +1 more source